MIT researchers have developed a groundbreaking method for gene editing that significantly reduces errors, making gene therapy safer and more effective for treating genetic diseases. This innovative approach promises a future of precise genomic alterations with fewer side effects.
A team of scientists proposes a bold plan to combat Lyme disease on Nantucket by genetically engineering mice to be immune, raising both hope and ecological concerns in the community.
A groundbreaking study reveals that the evolution of mammal digits may have originated from a genetic program linked to cloaca formation in fish, challenging previous assumptions about limb development.
The rollout of updated Covid vaccines is marred by confusion, misinformation, and access barriers, especially for marginalized communities. Experts warn these issues could have dire public health consequences.
A historic pig lung transplant into a brain-dead human patient lasted nine days, showcasing the potential and challenges of xenotransplantation. While the patient faced organ rejection, this experiment opens new avenues in medical science.
In a pioneering experiment, doctors in China successfully transplanted a genetically modified pig lung into a brain-dead patient, marking a significant step in xenotransplantation research despite challenges in organ rejection.
President Trump is set to sign an executive order to eliminate cashless bail in Washington, D.C., claiming it endangers public safety. Critics argue this policy disproportionately affects low-income individuals and lacks statistical support.
Researchers have discovered a groundbreaking CRISPR gene-editing method that modifies mosquitoes to prevent malaria transmission, potentially saving hundreds of thousands of lives annually.
In an unprecedented medical achievement, a child with a rare genetic disorder receives a customized CRISPR gene therapy, paving the way for future treatments of similar conditions.
In a groundbreaking achievement, scientists have developed the first gene-editing medicine tailored for a baby suffering from a rare DNA condition. After successful treatments, KJ Muldoon is now healthier and ready to go home, showcasing a promising future for gene therapies.
